Even if EZH2 is dispensable for the progression of prostate and mammary cancer, it is nonetheless highly expressed.118 In fact, in normally dividing cells, the rate of EZH2 expression correlates with proliferation rates,118 compensating the proliferation-dependent dilution of H3K27me3. Here, EZH2 is linked to breast cancer.